TY - JOUR
T1 - Colorectal Cancer Disparity in African Americans
T2 - Risk Factors and Carcinogenic Mechanisms
AU - Augustus, Gaius J.
AU - Ellis, Nathan A.
N1 - Publisher Copyright:
© 2018 American Society for Investigative Pathology
PY - 2018/2
Y1 - 2018/2
N2 - African Americans have the highest incidence and mortality rates of colorectal cancer (CRC) of any ethnic group in the United States. Although some of these disparities can be explained by differences in access to care, cancer screening, and other socioeconomic factors, disparities remain after adjustment for these factors. Consequently, an examination of recent advances in the understanding of ethnicity-specific factors, including genetic and environmental factors relating to risk of CRC, the biology of CRC progression, and the changes in screening and mortality, is important for evaluating our progress toward eliminating the disparities. An overarching limitation in this field is the number and sample size of studies performed to characterize the etiological bases of CRC incidence and mortality in African Americans. Despite this limitation, significant differences in etiology are manifest in many studies. These differences need validation, and their impacts on disparities need more detailed investigation. Perhaps most heartening, improvements in CRC screening can be attributed to the smallest difference in CRC incidence between African Americans and whites since the late 1980s. Cancer mortality, however, remains a persistent difference.
AB - African Americans have the highest incidence and mortality rates of colorectal cancer (CRC) of any ethnic group in the United States. Although some of these disparities can be explained by differences in access to care, cancer screening, and other socioeconomic factors, disparities remain after adjustment for these factors. Consequently, an examination of recent advances in the understanding of ethnicity-specific factors, including genetic and environmental factors relating to risk of CRC, the biology of CRC progression, and the changes in screening and mortality, is important for evaluating our progress toward eliminating the disparities. An overarching limitation in this field is the number and sample size of studies performed to characterize the etiological bases of CRC incidence and mortality in African Americans. Despite this limitation, significant differences in etiology are manifest in many studies. These differences need validation, and their impacts on disparities need more detailed investigation. Perhaps most heartening, improvements in CRC screening can be attributed to the smallest difference in CRC incidence between African Americans and whites since the late 1980s. Cancer mortality, however, remains a persistent difference.
UR - http://www.scopus.com/inward/record.url?scp=85044583162&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85044583162&partnerID=8YFLogxK
U2 - 10.1016/j.ajpath.2017.07.023
DO - 10.1016/j.ajpath.2017.07.023
M3 - Review article
C2 - 29128568
AN - SCOPUS:85044583162
SN - 0002-9440
VL - 188
SP - 291
EP - 303
JO - American Journal of Pathology
JF - American Journal of Pathology
IS - 2
ER -